๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: Response to therapy

โœ Scribed by VIVEK A SARASWAT; BARJESH C SHARMA; DEEPAK K AGARWAL; RAKESH KUMAR; TAJESHWAR S NEGI; RAKESH K TANDON

Book ID
111754999
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
69 KB
Volume
19
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term ursodeoxycholic acid therapy i
Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis
โœ Shinji Tomida; Masato Abei; Takashi Yamaguchi; Yasushi Matsuzaki; Junichi Shoda; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

Whether ursodeoxycholic acid (UDCA) therapy alters the long-term clinical course of gallstones (GS) without stone dissolution remains unknown. We aimed to clarify the relationship between long-term UDCA therapy and risks of biliary pain or acute cholecystitis in GS patients. We also aimed to identif

Does antimitochondrial antibody status a
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
โœ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 270 KB ๐Ÿ‘ 2 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri